Meningococcal disease: changes in epidemiology and prevention

References

• RouphaelNGStephensDSNeisseria meningitidis: biology, microbiology, and epidemiologyMethods Mol Biol201279912021993636
   PubMedGoogle Scholar
• RosensteinNEPerkinsBAStephensDSPopovicTHughesJMMeningococcal diseaseN Engl J Med2001344181378138811333996
   PubMed Web of Science ®Google Scholar
• GoldacreMJRobertsSEYeatesDCase fatality rates for meningococcal disease in an English population, 1963–1998: database studyBMJ2003327741559659712969927
   PubMed Web of Science ®Google Scholar
• TunkelARHartmanBJKaplanSLPractice guidelines for the management of bacterial meningitisClin Infect Dis20043991267128415494903
   PubMed Web of Science ®Google Scholar
• BilukhaOORosensteinNPrevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP)MMWR Recomm Rep200554RR-712115917737
   PubMedGoogle Scholar
• OsterPLennonDO’HallahanJMeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strainVaccine20052317–182191219615755593
   PubMed Web of Science ®Google Scholar
• RodriguezAPDickinsonFBalyAMartinezRThe epidemiological impact of antimeningococcal B vaccination in CubaMem Inst Oswaldo Cruz199994443344010445998
   PubMed Web of Science ®Google Scholar
• GallowayYStehr-GreenPMcNicholasAO’HallahanJUse of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 yearsInt J Epidemiol200938241341818988650
   PubMed Web of Science ®Google Scholar
• BrehonyCJolleyKAMaidenMCMultilocus sequence typing for global surveillance of meningococcal diseaseFEMS Microbiol Rev2007311152617168997
   PubMed Web of Science ®Google Scholar
• HarrisonLHTrotterCLRamsayMEGlobal epidemiology of meningococcal diseaseVaccine200927Suppl 2B51B6319477562
   PubMed Web of Science ®Google Scholar
• RosensteinNEPerkinsBAStephensDSThe changing epidemiology of meningococcal disease in the United States, 1992–1996J Infect Dis199918061894190110558946
   PubMed Web of Science ®Google Scholar
• CohnACMacNeilJRHarrisonLHChanges in Neisseria meningitidis disease epidemiology in the United States, 1998–2007: implications for prevention of meningococcal diseaseClin Infect Dis201050218419120001736
   PubMed Web of Science ®Google Scholar
• HarrisonLHEpidemiological profile of meningococcal disease in the United StatesClin Infect Dis201050Suppl 2S37S4420144015
   PubMed Web of Science ®Google Scholar
• HarrisonLHShuttKASchminkSEPopulation structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era – United States, 2000–2005J Infect Dis201020181208122420199241
   PubMed Web of Science ®Google Scholar
• CaugantDANicolasPMolecular surveillance of meningococcal meningitis in AfricaVaccine200725Suppl 1A8A1117521785
   PubMed Web of Science ®Google Scholar
• MolesworthAMCuevasLEConnorSJMorseAPThomsonMCEnvironmental risk and meningitis epidemics in AfricaEmerg Infect Dis20039101287129314609465
   PubMed Web of Science ®Google Scholar
• GreenwoodBMBradleyAKWallRAMeningococcal disease and season in sub-Saharan AfricaLancet1985284598298302864546
   PubMed Web of Science ®Google Scholar
• SultanBLabadiKGueganJFJanicotSClimate drives the meningitis epidemics onset in west AfricaPLoS Med200521e615696216
   PubMed Web of Science ®Google Scholar
• DiermayerMHedbergKHoeslyFEpidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strainJAMA1999281161493149710227318
   PubMed Web of Science ®Google Scholar
• RaclozVNLuizSJThe elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiologyBMC Infect Dis20101017520565757
   PubMed Web of Science ®Google Scholar
• SwartleyJSMarfinAAEdupugantiSCapsule switching of Neisseria meningitidisProc Natl Acad Sci U S A19979412712768990198
   PubMed Web of Science ®Google Scholar
• TroyFA2ndPolysialylation: from bacteria to brainsGlycobiology1992215231550990
   PubMed Web of Science ®Google Scholar
• SotolongoFCampaCCasanuevaVCuban meningococcal BC vaccine: experiences and contributions from 20 years of applicationMEDICC Rev200891162221483377
   PubMedGoogle Scholar
• de MoraesJCPerkinsBACamargoMCProtective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, BrazilLancet19923408827107410781357461
   PubMed Web of Science ®Google Scholar
• MilagresLGRamosSRSacchiCTImmune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacyInfect Immun19946210441944247927704
   PubMed Web of Science ®Google Scholar
• NoronhaCPStruchinerCJHalloranMEAssessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control studyInt J Epidemiol1995245105010578557439
   PubMed Web of Science ®Google Scholar
• RichmondPCMarshallHSNissenMDSafety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trialLancet Infect Dis201212859760722569484
   PubMed Web of Science ®Google Scholar
• SantolayaMEO’RyanMLValenzuelaMTImmunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled studyLancet2012379981661762422260988
   PubMed Web of Science ®Google Scholar
• GossgerNSnapeMDYuLMImmunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trialJAMA2012307657358222318278
   PubMed Web of Science ®Google Scholar
• CohnACMessonnierNEInching toward a serogroup B meningococcal vaccine for infantsJAMA2012307661461522318284
   PubMed Web of Science ®Google Scholar
• StephensDSPrevention of serogroup B meningococcal diseaseLancet2012379981659259422260987
   PubMed Web of Science ®Google Scholar
• Control ECfDPaAnnual epidemiological report 2011–Reporting on 2009 surveillance data and 2010 epidemic intelligence dataEuro Surveill201116452001222114980
   PubMedGoogle Scholar
• JacksonLAWengerJDLaboratory-based surveillance for meningococcal disease in selected areas, United States, 1989–1991MMWR CDC Surveill Summ199342221308510639
   PubMedGoogle Scholar
• KellermanSEMcCombsKRayMGenotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal diseaseJ Infect Dis20021861404812089660
   PubMed Web of Science ®Google Scholar
• ClarkTASternEPondoTThe effect of quadrivalent (A, C, Y, W-135) meningococcal conjugate vaccine on serogroup-specific carriage of Neisseria meningitidisPresented at the 16th International Pathogenic Neissera conferenceRotterdam, The NetherlandsSeptember 7–12, 2008
   Google Scholar
• AbadRAgudeloCIBrandileoneMCMolecular characterization of invasive serogroup Y Neisseria meningitidis strains isolated in the Latin America regionJ Infect200959210411419576638
   PubMed Web of Science ®Google Scholar
• WhitneyAMCoulsonGBvon GottbergAGenotypic comparison of invasive Neisseria meningitidis serogroup Y isolates from the United States, South Africa, and Israel, isolated from 1999 through 2002J Clin Microbiol20094792787279319571028
   PubMed Web of Science ®Google Scholar
• TsangRSHendersonAMCameronMLGenetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in CanadaJ Clin Microbiol20074561753175817442798
   PubMed Web of Science ®Google Scholar
• MateruSCoxHSIsaakidisPSerogroup X in meningococcal disease, Western KenyaEmerg Infect Dis200713694494517582900
   PubMed Web of Science ®Google Scholar
• GagneuxSWirthTHodgsonAClonal groupings in serogroup X Neisseria meningitidisEmerg Infect Dis20028546246611996679
   PubMed Web of Science ®Google Scholar
• GagneuxSPHodgsonASmithTAProspective study of a serogroup X Neisseria meningitidis outbreak in northern GhanaJ Infect Dis2002185561862611865418
   PubMed Web of Science ®Google Scholar
• BoisierPNicolasPDjiboSMeningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in NigerClin Infect Dis200744565766317278055
   PubMed Web of Science ®Google Scholar
• DelrieuIYaroSTamekloeTAEmergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina FasoPLoS One201165e1951321625480
   PubMed Web of Science ®Google Scholar
• AguileraJFPerrocheauAMeffreCHahneSGroupWWOutbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000Emerg Infect Dis20028876176712141959
   PubMed Web of Science ®Google Scholar
• RaghunathanPLJonesJDTiendrebeogoSRPredictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002J Infect Dis2006193560761616453255
   PubMed Web of Science ®Google Scholar
• MayerLWReevesMWAl-HamdanNOutbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complexJ Infect Dis2002185111596160512023765
   PubMed Web of Science ®Google Scholar
• StephensDSGreenwoodBBrandtzaegPEpidemic meningitis, meningococcaemia, and Neisseria meningitidisLancet200736995802196221017604802
   PubMed Web of Science ®Google Scholar
• LiuTYGotschlichECDunneFTJonssenEKStudies on the meningococcal polysaccharides. II. Composition and chemical properties of the group B and group C polysaccharideJ Biol Chem197124615470347124327325
   PubMed Web of Science ®Google Scholar
• BhattacharjeeAKJenningsHJKennyCPMartinASmithICStructural determination of the polysaccharide antigens of Neisseria meningitidis serogroups Y, W-135, and BO1Can J Biochem197654118814976
   PubMedGoogle Scholar
• LiuTYGotschlichECJonssenEKWysockiJRStudies on the meningococcal polysaccharides. I. Composition and chemical properties of the group A polysaccharideJ Biol Chem19712469284928584995120
   PubMed Web of Science ®Google Scholar
• BundleDRJenningsHJKennyCPStudies on the group-specific polysaccharide of Neisseria meningitidis serogroup X and an improved procedure for its isolationJ Biol Chem197424915479748014211095
   PubMed Web of Science ®Google Scholar
• DavidsenTTonjumTMeningococcal genome dynamicsNat Rev Microbiol200641112216357857
   PubMed Web of Science ®Google Scholar
• HillDJGriffithsNJBorodinaEVirjiMCellular and molecular biology of Neisseria meningitidis colonization and invasive diseaseClin Sci (Lond)2010118954756420132098
   PubMed Web of Science ®Google Scholar
• KrizPGiorginiDMusilekMLarribeMTahaMKMicroevolution through DNA exchange among strains of Neisseria meningitidis isolated during an outbreak in the Czech RepublicRes Microbiol1999150427328010376489
   PubMed Web of Science ®Google Scholar
• van der EndeAHopmanCTDankertJDeletion of porA by recombination between clusters of repetitive extragenic palindromic sequences in Neisseria meningitidisInfect Immun19996762928293410338501
   PubMed Web of Science ®Google Scholar
• BerringtonAWTanYCSrikhantaYPhase variation in meningococcal lipooligosaccharide biosynthesis genesFEMS Immunol Med Microbiol200234426727512443826
   PubMedGoogle Scholar
• HammerschmidtSMullerASillmannHCapsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal diseaseMol Microbiol1996206121112208809773
   PubMed Web of Science ®Google Scholar
• HammerschmidtSHilseRvan PuttenJPModulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic elementEMBO J19961511921988598202
   PubMed Web of Science ®Google Scholar
• CahoonLASeifertHSFocusing homologous recombination: pilin antigenic variation in the pathogenic NeisseriaMol Microbiol20118151136114321812841
   PubMed Web of Science ®Google Scholar
• HelmRASeifertHSFrequency and rate of pilin antigenic variation of Neisseria meningitidisJ Bacteriol2010192143822382320472803
   PubMed Web of Science ®Google Scholar
• AndrewsTDGojoboriTStrong positive selection and recombination drive the antigenic variation of the PilE protein of the human pathogen Neisseria meningitidisGenetics20041661253215020403
   PubMed Web of Science ®Google Scholar
• BudroniSSienaEHotoppJCNeisseria meningitidis is structured in clades associated with restriction modification systems that modulate homologous recombinationProc Natl Acad Sci U S A2011108114494449921368196
   PubMed Web of Science ®Google Scholar
• TzengYLDattaAAmbroseKDThe MisR/MisS two-component regulatory system influences inner core structure and immunotype of lipooligosaccharide in Neisseria meningitidisJ Biol Chem2004279350533506215173178
   PubMed Web of Science ®Google Scholar
• AlcalaBArreazaLSalcedoCCapsule switching among C:2b:P1.2,5 meningococcal epidemic strains after mass immunization campaign, SpainEmerg Infect Dis20028121512151412498676
   PubMed Web of Science ®Google Scholar
• SimoesMJCunhaMAlmeidaFFurtadoCBrumLMolecular surveillance of Neisseria meningitidis capsular switching in Portugal, 2002–2006Epidemiol Infect2009137216116518667108
   PubMed Web of Science ®Google Scholar
• StefanelliPFazioCNeriASofiaTMastrantonioPFirst report of capsule replacement among electrophoretic type 37 Neisseria meningitidis strains in ItalyJ Clin Microbiol200341125783578614662983
   PubMed Web of Science ®Google Scholar
• KerteszDACoulthartMBRyanJAJohnsonWMAshtonFESerogroup B, electrophoretic type 15 Neisseria meningitidis in CanadaJ Infect Dis19981776175417579607865
   PubMed Web of Science ®Google Scholar
• TsangRSLawDKTylerSDPotential capsule switching from serogroup Y to B: The characterization of three such Neisseria meningitidis isolates causing invasive meningococcal disease in CanadaCan J Infect Dis Med Microbiol200516317117418159539
   PubMedGoogle Scholar
• BalmerPBorrowRMillerEImpact of meningococcal C conjugate vaccine in the UKJ Med Microbiol200251971772212358061
   PubMed Web of Science ®Google Scholar
• StephensDSUncloaking the meningococcus: dynamics of carriage and diseaseLancet1999353915794194210459897
   PubMed Web of Science ®Google Scholar
• GoldschneiderIGotschlichECArtensteinMSHuman immunity to the meningococcus. I. The role of humoral antibodiesJ Exp Med19691296130713264977280
   PubMed Web of Science ®Google Scholar
• BishofNAWelchTRBeischelLSC4B deficiency: a risk factor for bacteremia with encapsulated organismsJ Infect Dis199016212482502355198
   PubMed Web of Science ®Google Scholar
• HogasenKMichaelsenTMellbyeOJBjuneGLow prevalence of complement deficiencies among patients with meningococcal disease in NorwayScand J Immunol19933744874898469932
   PubMed Web of Science ®Google Scholar
• WestendorpRGLangermansJAde BelCERelease of tumor necrosis factor: an innate host characteristic that may contribute to the outcome of meningococcal diseaseJ Infect Dis19951714105710607706790
   PubMed Web of Science ®Google Scholar
• NadelSNewportMJBooyRLevinMVariation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal diseaseJ Infect Dis199617448788808843235
   PubMed Web of Science ®Google Scholar
• WestendorpRGLangermansJAHuizingaTWGenetic influence on cytokine production and fatal meningococcal diseaseLancet199734990461701739111542
   PubMed Web of Science ®Google Scholar
• VermontCLde GrootRHazelzetJABench-to-bedside review: genetic influences on meningococcal diseaseCrit Care200261606511940267
   PubMed Web of Science ®Google Scholar
• HaralambousEDollySOHibberdMLFactor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patientsScand J Infect Dis200638976477116938729
   PubMed Web of Science ®Google Scholar
• HanebergBTonjumTRodahlKGedde-DahlTWFactors preceding the onset of meningococcal disease, with special emphasis on passive smoking, symptoms of ill healthNIPH Ann1983621691736676682
   PubMedGoogle Scholar
• CoenPGTullyJStuartJMIs it exposure to cigarette smoke or to smokers which increases the risk of meningococcal disease in teenagers?Int J Epidemiol200635233033616394119
   PubMed Web of Science ®Google Scholar
• FischerMHedbergKCardosiPTobacco smoke as a risk factor for meningococcal diseasePediatr Infect Dis J199716109799839380476
   PubMed Web of Science ®Google Scholar
• YusufHRRochatRWBaughmanWSMaternal cigarette smoking and invasive meningococcal disease: a cohort study among young children in metropolitan Atlanta, 1989–1996Am J Public Health199989571271710224983
   PubMed Web of Science ®Google Scholar
• CartwrightKAJonesDMSmithAJInfluenza A and meningococcal diseaseLancet199133887665545571678811
   PubMed Web of Science ®Google Scholar
• BakerMMcNicholasAGarrettNHousehold crowding a major risk factor for epidemic meningococcal disease in Auckland childrenPediatr Infect Dis J2000191098399011055601
   PubMed Web of Science ®Google Scholar
• DeutchSLabouriauRSchonheyederHCCrowding as a risk factor of meningococcal disease in Danish preschool children: a nationwide population-based case-control studyScand J Infect Dis2004361202315000554
   PubMed Web of Science ®Google Scholar
• OlcenPKjellanderJDanielssonDLindquistBLEpidemiology of Neisseria meningitidis; prevalence and symptoms from the upper respiratory tract in family members to patients with meningococcal diseaseScand J Infect Dis19811321051096797052
   PubMedGoogle Scholar
• HudsonPJVogtRLHeunEMEvidence for school transmission of Neisseria meningitidis during a Vermont outbreakPediatr Infect Dis1986522132173081880
   PubMedGoogle Scholar
• NealKRNguyen-Van-TamJSJeffreyNChanging carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional studyBMJ2000320723884684910731181
   PubMed Web of Science ®Google Scholar
• BrooksRWoodsCWBenjaminDKJrRosensteinNEIncreased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994–2002Clin Infect Dis2006431495416758417
   PubMed Web of Science ®Google Scholar
• MacDonaldNEHalperinSALawBJInduction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trialJAMA199828019168516899832000
   PubMed Web of Science ®Google Scholar
• StephensDSProtecting the herd: the remarkable effectiveness of the bacterial meningitis polysaccharide-protein conjugate vaccines in altering transmission dynamicsTrans Am Clin Climatol Assoc201112211512321686214
   PubMedGoogle Scholar
• MaidenMCIbarz-PavonABUrwinRImpact of meningococcal serogroup C conjugate vaccines on carriage and herd immunityJ Infect Dis2008197573774318271745
   PubMed Web of Science ®Google Scholar
• HarrisonLHMohanNKirkpatrickPMeningococcal group A, C, Y and W-135 conjugate vaccineNat Rev Drug Discov20109642943020514064
   PubMed Web of Science ®Google Scholar
• PichicheroMEMeningococcal conjugate vaccinesExpert Opin Biol Ther20055111475148916255651
   PubMed Web of Science ®Google Scholar
• HalperinSAGuptaAJeanfreauRComparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2–10 years of ageVaccine201028507865787220943209
   PubMed Web of Science ®Google Scholar
• Marc LaForceFRavenscroftNDjingareyMVivianiSEpidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solutionVaccine200927Suppl 2B13B1919477559
   PubMed Web of Science ®Google Scholar
• BishaiDMChampionCSteeleMEThompsonLProduct development partnerships hit their stride: lessons from developing a meningitis vaccine for AfricaHealth Aff (Millwood)20113061058106421653957
   PubMed Web of Science ®Google Scholar
• FraschCPreziosiMPLaforceFMDevelopment of a group A meningococcal conjugate vaccine, MenAfriVac (TM)Hum Vaccin Immunother201286 [Epub ahead of print.]
   Web of Science ®Google Scholar
• DjingareyMHBarryRBonkoungouMEffectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experienceVaccine201230Suppl 2B40B4522607898
   PubMed Web of Science ®Google Scholar
• McCoyRDVimrERTroyFACMP-NeuNAc:poly-alpha-2,8-sialosyl sialyltransferase and the biosynthesis of polysialosyl units in neural cell adhesion moleculesJ Biol Chem19852602312695126994044605
   PubMed Web of Science ®Google Scholar
• HolstJStrategies for development of universal vaccines against meningococcal serogroup B disease: the most promising options and the challenges evaluating themHum Vaccin20073629029417712231
   PubMed Web of Science ®Google Scholar
• Dolan-LivengoodJMMillerYKMartinLEUrwinRStephensDSGenetic basis for nongroupable Neisseria meningitidisJ Infect Dis2003187101616162812721942
   PubMed Web of Science ®Google Scholar